A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

As Frontiers Health 2024 approaches, taking place in Berlin 17th and 18th October, pharmaphorum sat down with one of its ...

FDA published a JAMA article on October 15, 2024, describing several areas of focus for regulation of AI used in the medical products. The JAMA article follows a June 2024 FDA blog post by Troy Tazbaz ...

Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...

In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of ...

A groundbreaking study has unveiled a potential game-changer in the fight against Alzheimer's disease. Scientists have ...

Emory wins $8.3 million grant from the National Institutes for Health that will support a project that aims to develop novel ...

Laos and China have deepened their cooperation in traditional medicine, focusing on medical plant cultivation, research, and ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...

A recent study has shown an experimental drug, called RK-33, holds promise in treating breast cancer with bone metastases, ...